Expertise

Navigating the Transition: How Medalogix Muse Supports Hospice Agencies in the Shift from HIS to HOPE

The hospice industry is no stranger to challenges. From regulatory chang...

Forcura and Medalogix Join to Create Transformative Post-Acute Care Technology Platform

Berkshire Partners Will Serve as Lead Investor in the New Platform, with...

A winning strategy for Home Health Providers

HHVBP: A Winning Strategy for Home Health Providers 

The start of 2025 has ushered in a wave of new realities for Home Health...

Pulse Episodes sees rapid growth, now supports over 25% of US Home Health Average Daily Census 

[Nashville, January 2, 2025] Medalogix, the leading data science and cli...

How Hospice Agencies Can Leverage Technology to Flourish Under New CMS Hospice Requirements 

Summary:  Hospice agencies face consistent headwinds, among them...

Monitoring Mortality Risk using Medalogix Helps Providers Reduce Death on Home Health Census by 52%

NASHVILLE, Tenn., November 22, 2024 -- Medalogix, the leading machine le...

Pulse Referrals & Admissions: Real-world AI impact in a sea of hype

Throughout the tech space, including home health, much has been said rec...

Successfully Navigating the “Grey Area” between Home Health and Hospice: Considerations and Strategies for Home Health Operators 

Amanda Fabozzi, PT, DPT Whether a patient should be served by hom...

Predictive analytics improve hospice transition evaluations for better patient care.

As patients approach the final months of their lives, their needs change...

Driving an improved home health patient experience with Pulse 

The Medalogix suite of products spans a patient’s full home health exper...

CY2025 Hospice Final Rule presents challenges, opportunities for agencies 

The CMS 2025 Hospice Final Rule furthers CMS’s multiyear trajectory towa...

Navigating CY 2025 Home Health Reimbursement Cuts: Medalogix Offers Innovative Solutions to Enhance Efficiency and Outcomes 

As the Home Health industry grapples with the CY 2025 proposed rule, we ...